Owens & Minor (NYSE:OMI) Issues FY25 Earnings Guidance

Owens & Minor (NYSE:OMI) updated its FY25 earnings guidance on Friday. The company provided EPS guidance of $1.60-1.85 for the period, compared to the consensus EPS estimate of $1.79. The company issued revenue guidance of $10.85-11.15, compared to the consensus revenue estimate of $10.97 billion. Owens & Minor also updated its FY 2025 guidance to 1.600-1.850 EPS.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Robert W. Baird lowered their target price on shares of Owens & Minor from $14.00 to $10.00 and set a “neutral” rating on the stock in a research note on Tuesday. Citigroup lowered their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research note on Tuesday, November 5th. UBS Group lowered their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Finally, Barclays lowered their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 5th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Owens & Minor has a consensus rating of “Hold” and a consensus price target of $14.92.

Owens & Minor Stock Performance

Owens & Minor stock opened at $9.56 on Friday. The firm’s 50 day simple moving average is $11.51 and its 200-day simple moving average is $13.26. The company has a market cap of $736.78 million, a P/E ratio of -14.70, a price-to-earnings-growth ratio of 0.20 and a beta of 0.48. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. Owens & Minor has a fifty-two week low of $6.07 and a fifty-two week high of $28.35.

Owens & Minor (NYSE:OMI) last released its earnings results on Friday, February 28th. The company reported $0.55 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.02. The business had revenue of $2.70 billion for the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period last year, the firm posted $0.69 earnings per share. As a group, equities research analysts predict that Owens & Minor will post 1.51 EPS for the current year.

Owens & Minor declared that its board has authorized a stock repurchase program on Friday, February 28th that permits the company to repurchase $100.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 13.6% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s board of directors believes its stock is undervalued.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.